Title
Category
Credits
Event date
Cost
Clinical Conversations: Gene Therapy for Sickle Cell Disease
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This patient‑led interview offers a compelling perspective on the real‑world impact of gene therapy for sickle cell disease, highlighting both dramatic physical improvements and the psychological and social adjustments that can follow transformative treatment. Through the patient’s lived experience, learners gain insight into how gene therapy may redefine identity, daily functioning, and long‑term expectations for health. The interview emphasizes the importance of patient‑centered communication, listening to patient expertise, and supporting ongoing mental and emotional adaptation as part of comprehensive, team‑based care.
Clinical Conversations: Gene Therapy
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview explores the rapidly evolving role of gene therapy through a practical, clinician‑focused lens. Rather than emphasizing future speculation, the discussion centers on what health care professionals need to know now—how gene-based therapies are entering clinical practice, current understanding of safety and efficacy and the role of clinicians across care settings. By addressing common knowledge gaps between specialists and primary care clinicians and using relatable comparisons to established therapies, the interview highlights the importance of patient education, interdisciplinary communication and timely referral as gene‑based treatments continue to expand.
Clinical Conversations: Fatty Liver Disease
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview equips clinicians with practical strategies to identify and manage metabolic‑associated fatty liver disease in everyday practice. Emphasizing early detection in an often asymptomatic population, the discussion focuses on using cardiometabolic risk factors and simple, noninvasive tools such as fibrosis 4 (FIB‑4) to stratify risk and guide next steps. By reinforcing a stepwise, team‑based approach to evaluation, referral and evidence‑based management, the interview helps learners translate emerging advances into timely, actionable care for patients at risk.
Gene Therapy in the Genomic Era: Promise, Progress and Patient Impact
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Gene therapy technologies are revolutionizing treatment for genetic diseases. This session explores the science, clinical applications, and patient perspectives, with a focus on sickle cell disease and emerging technologies like CRISPR.
COPD in 2025: Early Detection, Diagnostic Precision, and Emerging Therapies
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
This session explores the latest updates in the diagnosis and management of chronic obstructive pulmonary disease (COPD) as outlined in the 2025 GOLD Report. Early case finding, refined spirometry protocols and novel therapeutic options are discussed, along with the importance of pre-bronchodilator spirometry, strategies for early detection in at-risk populations, and the integration of new treatments into updated treatment algorithms.
Heart Failure at the Crossroads: Early Recognition and Proactive Management
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Heart failure remains a leading cause of hospitalization and mortality. This session focuses on recognizing early signs, diagnostic tools, and evidence-based strategies to optimize care, improve patient quality of life, and reduce readmissions.
The Impact of Aging, Hearing Loss and Cognitive Burden on Health Literacy on Older Adults
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will discuss the association between hearing loss and cognitive burden, as well as the potential impact of untreated hearing loss. It will provide communication and management techniques for caregivers to accommodate changes in the cognitive status of those with hearing loss, as well as tools and strategies that are recommended by the Hearing Loss Association of America (HLAA) and how these can be put into practice.
GLP-1 Agonists in Practice: A New Era in Obesity and Diabetes Management
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
GLP-1 receptor agonists have reshaped the landscape of obesity and type 2 diabetes management, offering benefits beyond glycemic control. This session explores their mechanisms, clinical applications, and emerging evidence on their implications for broader metabolic care and in the treatment of obesity-related conditions such as obstructive sleep apnea.
Understanding and Preventing Burnout: Improving Health Care Outcomes
  • Behavioral health
  • Wellness
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity will discuss contributing factors to burnout, its impact on the health and well-being of HCPs and their patients, interventions to decrease overall stress and how burnout can influence patient care and health care outcomes.
Optimizing Value in Transplant Candidates with End-Stage Liver Disease with Organ Preservation
  • Disease management
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 APA - Psychologists
  • 0.50 Attendance - General Attendance
  • 0.50 CDR - Dietitians
  • 0.50 ASWB - Social Workers
$0.00
Essentials of Oncology and Transplant Management is designed for all who are interested in learning best practices for optimal patient and/or benefit management in the fields of transplant medicine and oncology.

Pages